SEC 13F Intelligence

Natixis Advisors, LLC / PFE

Natixis Advisors, LLC’s Pfizer Inc Position

Does Natixis Advisors, LLC own Pfizer Inc (PFE)? Yes — 2.71M shares worth $76M (+0.11% of its 13F portfolio) as of Q1 2026, up from 2.21M shares the prior filed quarter.

Position Value
$76M
Q1 2026
Shares
2.71M
% of Portfolio
+0.11%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $64MQ4 ’18Q1 ’19: $58MQ2 ’19: $58MQ3 ’19: $42MQ4 ’19: $55MQ4 ’19Q1 ’20: $40MQ2 ’20: $39MQ3 ’20: $38MQ4 ’20: $31MQ4 ’20Q1 ’21: $29MQ2 ’21: $34MQ3 ’21: $37MQ4 ’21: $66MQ4 ’21Q1 ’22: $83MQ2 ’22: $86MQ3 ’22: $58MQ4 ’22: $110MQ4 ’22Q1 ’23: $50MQ2 ’23: $90MQ3 ’23: $46MQ4 ’23: $36MQ4 ’23Q1 ’24: $61MQ2 ’24: $73MQ3 ’24: $69MQ4 ’24: $59MQ4 ’24Q1 ’25: $64MQ2 ’25: $55MQ3 ’25: $44MQ4 ’25: $55MQ4 ’25Q1 ’26: $76Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.71M$76M+0.11%
Q4 20252.21M$55M+0.08%
Q3 20251.73M$44M+0.06%
Q2 20252.25M$55M+0.09%
Q1 20252.54M$64M+0.12%
Q4 20242.22M$59M+0.11%
Q3 20242.40M$69M+0.14%
Q2 20242.60M$73M+0.16%
Q1 20242.21M$61M+0.14%
Q4 20231.23M$36M+0.09%
Q3 20231.39M$46M+0.14%
Q2 20232.45M$90M+0.28%
Q1 20231.22M$50M+0.17%
Q4 20222.15M$110M+0.42%
Q3 20221.33M$58M+0.25%
Q2 20221.65M$86M+0.38%
Q1 20221.60M$83M+0.32%
Q4 20211.12M$66M+0.25%
Q3 2021866.2K$37M+0.15%
Q2 2021859.6K$34M+0.16%
Q1 2021794.0K$29M+0.15%
Q4 2020843.6K$31M+0.18%
Q3 20201.02M$38M+0.24%
Q2 20201.19M$39M+0.26%
Q1 20201.21M$40M+0.32%
Q4 20191.41M$55M+0.39%
Q3 20191.17M$42M+0.33%
Q2 20191.33M$58M+0.47%
Q1 20191.36M$58M+0.50%
Q4 20181.46M$64M+0.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of PFE.